As the industry struggles to adapt to the growing demand of justifying the value of a product or service, payers and pharmacy benefit managers are negotiating indication or outcome-based pricing proposals with manufacturers. Leading the way is Express Scripts. According to president Tim Wentworth, the PBM “saved our clients more than $3 billion through the Express Scripts National Preferred Formulary and $2 billion through novel compound drug management solutions.” He was speaking on the evening of the first day of the JP Morgan Healthcare Conference. - See more at: http://www.ajmc.com/newsroom/5-things-from-the-jp-morgan-healthcare-conference#sthash.Pt5utheL.dpuf